Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CODXNASDAQ:LNSRNYSE:RVPNASDAQ:UTRS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$0.26-1.6%$0.30$0.23▼$2.23$8.81M0.58247,305 shs577,921 shsLNSRLENSAR$12.76+1.7%$13.43$3.50▼$17.31$150.44M0.5290,358 shs1.33 million shsRVPRetractable Technologies$0.62-6.3%$0.69$0.56▼$1.21$18.56M1.3967,596 shs60,398 shsUTRSMinerva Surgical$0.00$0.00▼$0.00$1K3.67259 shsN/A2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics0.00%+0.31%+0.19%-15.21%-79.00%LNSRLENSAR0.00%+2.82%-6.11%-9.63%+183.56%RVPRetractable Technologies0.00%-1.98%-4.62%-11.87%-42.59%UTRSMinerva Surgical0.00%0.00%0.00%0.00%-99.17%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCODXCo-Diagnostics4.4815 of 5 stars3.55.00.04.42.20.01.3LNSRLENSAR1.3168 of 5 stars2.03.00.00.02.22.50.0RVPRetractable TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AUTRSMinerva SurgicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCODXCo-Diagnostics 3.00Buy$5.501,995.24% UpsideLNSRLENSAR 2.00Hold$15.0017.55% UpsideRVPRetractable Technologies 0.00N/AN/AN/AUTRSMinerva Surgical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LNSR, UTRS, CODX, and RVP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CODXCo-DiagnosticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCODXCo-Diagnostics$3.91M2.25N/AN/A$1.70 per share0.15LNSRLENSAR$53.49M2.81N/AN/A$0.42 per share30.38RVPRetractable Technologies$33.75M0.55$0.01 per share48.25$3.31 per share0.19UTRSMinerva Surgical$51.69M0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCODXCo-Diagnostics-$37.64M-$1.17N/AN/AN/A-1,025.45%-60.16%-52.69%8/6/2025 (Estimated)LNSRLENSAR-$31.40M-$4.85N/A∞N/A-99.17%-737.30%-81.69%8/6/2025 (Estimated)RVPRetractable Technologies-$7.01M-$0.77N/A∞N/A-41.11%-17.15%-9.33%N/AUTRSMinerva Surgical-$34.11MN/A0.00N/AN/AN/AN/AN/AN/ALatest LNSR, UTRS, CODX, and RVP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CODXCo-Diagnostics-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 million5/8/2025Q1 2025LNSRLENSAR-$0.1550-$2.32-$2.1650-$2.32$13.40 million$11.53 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCODXCo-DiagnosticsN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/AUTRSMinerva SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCODXCo-DiagnosticsN/A4.434.23LNSRLENSARN/A1.811.25RVPRetractable Technologies0.018.575.92UTRSMinerva SurgicalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCODXCo-Diagnostics14.99%LNSRLENSAR40.15%RVPRetractable Technologies7.58%UTRSMinerva SurgicalN/AInsider OwnershipCompanyInsider OwnershipCODXCo-Diagnostics6.10%LNSRLENSAR66.00%RVPRetractable Technologies57.10%UTRSMinerva Surgical8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCODXCo-Diagnostics10033.57 million31.53 millionOptionableLNSRLENSAR11011.79 million4.01 millionOptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableUTRSMinerva Surgical1608.88 million8.12 millionNot OptionableLNSR, UTRS, CODX, and RVP HeadlinesRecent News About These CompaniesMinerva Surgical Inc.January 10, 2024 | thestreet.comWhy Is Minerva Surgical (UTRS) Stock Down 50% Today?December 18, 2023 | markets.businessinsider.comMinerva Surgical Inc UTRSDecember 17, 2023 | morningstar.comMMinerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finanznachrichten.deMinerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93MNovember 14, 2023 | msn.comMinerva Surgical Reports Third Quarter 2023 Financial ResultsNovember 13, 2023 | finance.yahoo.comAccelmed Files Transaction Statement on Schedule 13E-3 with Securities and Exchange CommissionSeptember 29, 2023 | finance.yahoo.comMinerva Surgical Inc (UTRS) Becoming More Attractive for InvestorsSeptember 27, 2023 | knoxdaily.comKUTRS Shares Experience Surge in ValueAugust 25, 2023 | knoxdaily.comKMinerva Surgical Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comMinerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue EstimatesAugust 3, 2023 | finance.yahoo.comInvestors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past weekMay 25, 2023 | finance.yahoo.comPatent Grant Sends Healthcare Shares Soaring PremarketMay 24, 2023 | theglobeandmail.comWhy Minerva Surgical Shares Are Taking Off WednesdayMay 24, 2023 | msn.comWhy Is Minerva Surgical (UTRS) Stock Up 229% Today?May 24, 2023 | msn.comQ1 2023 Minerva Surgical Inc Earnings CallMay 3, 2023 | finance.yahoo.comMinerva Surgical Reports First Quarter 2023 Financial ResultsMay 2, 2023 | finance.yahoo.comModified Minerva orthosis proven helpful in pediatric patients following airway surgeryMay 2, 2023 | medicalxpress.comMMinerva Surgical to Announce First Quarter 2023 Financial ResultsApril 18, 2023 | finance.yahoo.comMinerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call TranscriptMarch 24, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLNSR, UTRS, CODX, and RVP Company DescriptionsCo-Diagnostics NASDAQ:CODX$0.26 0.00 (-1.65%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.95 +1.69 (+642.86%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.LENSAR NASDAQ:LNSR$12.76 +0.21 (+1.67%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$12.85 +0.09 (+0.71%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.Retractable Technologies NYSE:RVP$0.62 -0.04 (-6.27%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.65 +0.03 (+5.32%) As of 04:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Minerva Surgical NASDAQ:UTRSMinerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
